HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kunitaka Hirose Selected Research

KRH 1636

4/2003A duodenally absorbable CXC chemokine receptor 4 antagonist, KRH-1636, exhibits a potent and selective anti-HIV-1 activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kunitaka Hirose Research Topics

Disease

2Neoplasms (Cancer)
11/2011 - 03/2005
2Rheumatoid Arthritis
08/2008 - 03/2004
1Vesicular Stomatitis
01/2015
1Breast Neoplasms (Breast Cancer)
11/2011
1Neoplasm Metastasis (Metastasis)
03/2005
1Infections
04/2003
1Melanoma (Melanoma, Malignant)
02/2003

Drug/Important Bio-Agent (IBA)

2CytokinesIBA
08/2008 - 03/2004
1Glycoproteins (Glycoprotein)IBA
01/2015
1Green Fluorescent ProteinsIBA
01/2015
1Immunoglobulin G (IgG)IBA
11/2011
1Platelet Factor 4IBA
03/2005
1Recombinant ProteinsIBA
03/2005
1Angiogenesis InhibitorsIBA
03/2005
1KRH 1636IBA
04/2003
1VitronectinIBA
02/2003

Therapy/Procedure

1Immunotherapy
11/2011